Predicting kidney function after partial nephrectomy with AI
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial uses a special computer model to predict how well your kidneys will work after surgery to remove part of a kidney (partial nephrectomy). It may help doctors plan better care for people with early-stage kidney tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a stage cT1 kidney tumor confirmed by CT or MRI
- You are scheduled for partial nephrectomy surgery
- Your tumor is localized and has not spread to lymph nodes or other organs
- You have a good performance status (ECOG score 0 or 1)
- Your life expectancy is more than 10 years
- Your kidney function is normal (eGFR of 90 or higher)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a 3D kidney model made with artificial intelligence helps surgeons remove a kidney tumor (partial nephrectomy) more precisely. It may help preserve healthy kidney tissue while treating the cancer.
This trial uses special ultrasound techniques to predict how well your remaining kidney will work after surgery to remove part or all of one kidney. It may help doctors understand your recovery and tailor follow-up care.
This study uses artificial intelligence to help plan the best surgery for kidney tumors. You may be eligible if you have a kidney tumor that can be removed with surgery and have had a special CT scan within the past month.
This study tests a robot-assisted surgery to remove part of the kidney for T1 tumors without clamping the main artery, which may help preserve kidney function. It may be an option for patients who are healthy enough for major surgery and have a small, early-stage kidney tumor.
This clinical trial is testing whether a medicine called ursodeoxycholic acid (UDCA) can help protect the kidneys during partial nephrectomy (removing only the tumor while keeping the healthy part of the kidney). It is for people with early-stage kidney tumors who will have temporary interruption of blood flow to the kidney during surgery.
This study uses a computer model to analyze your CT scans and predict how long you might stay cancer-free after surgery. It aims to help doctors personalize follow-up care for clear cell kidney cancer.
Hear when a new Renal Cell Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.